Literature DB >> 9029087

Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo.

J A Hedrick1, V Saylor, D Figueroa, L Mizoue, Y Xu, S Menon, J Abrams, T Handel, A Zlotnik.   

Abstract

Injection of lymphotactin (Lptn) into the peritoneum caused an influx of lymphocytes at 24 h. Phenotypic analysis of the cellular influx showed that a large proportion of these cells were T lymphocytes; however, a large number of NK cells was also present. This effect of murine Lptn (mLptn) was specific since the cellular influx was blocked with a mLptn-specific mAb. Similar results were observed when Lptn was injected s.c. and the tissue was analyzed by immunohistochemistry using an anti-CD3epsilon mAb. Microchemotaxis assays confirmed that murine NK cells respond to mLptn, and also showed human NK clones to be similarly responsive to recombinant human Lptn (rhLptn). Immunohistochemical analysis of IL-2-activated murine NK cells and Northern analysis of human NK clones revealed that these cells also produce Lptn, suggesting that a self-regulatory migration mechanism exists in NK cells. Together these data confirm, in vivo, the lymphocyte specificity of Lptn previously observed in vitro and extend its chemotactic effects to the NK cell lineage. We also investigated the functional consequences of truncating the carboxyl terminus of hLptn. This truncated molecule (which is missing the carboxyl-terminal 22 amino acids of hLptn) had no detectable activity on human PBLs. In addition, while hLptn was found to attract murine splenocytes in vitro, the carboxyl-terminal truncated hLptn was again inactive on murine splenocytes. This observation indicates the presence of structural features in the carboxyl terminus of Lptn that are necessary for its biologic activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029087

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Interleukin 12 and innate molecules for enhanced mucosal immunity.

Authors:  P N Boyaka; J W Lillard; J McGhee
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Chemokines and central nervous system disorders.

Authors:  W J Karpus
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

3.  Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major.

Authors:  Colby Zaph; Phillip Scott
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  Mycobacterium tuberculosis antigen Wag31 induces expression of C-chemokine XCL2 in macrophages.

Authors:  Wei Cao; Shuai Tang; Hanying Yuan; Honghai Wang; Xin Zhao; Hong Lu
Journal:  Curr Microbiol       Date:  2008-07-11       Impact factor: 2.188

5.  MIP-3alpha, MIP-3beta and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells.

Authors:  A Al-Aoukaty; B Rolstad; A Giaid; A A Maghazachi
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

6.  Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions.

Authors:  E Sonay Kuloğlu; Darrell R McCaslin; John L Markley; Brian F Volkman
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

Review 7.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

8.  Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

Authors:  Junko Yokokawa; Claudia Palena; Philip Arlen; Raffit Hassan; Mitchell Ho; Ira Pastan; Jeffrey Schlom; Kwong Y Tsang
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

9.  Expression of lymphotactin mRNA in experimental crescentic glomerulonephritis.

Authors:  Y Natori; Z L Ou; Y Yamamoto-Shuda; Y Natori
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

10.  Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.

Authors:  E S Kuloglu; D R McCaslin; M Kitabwalla; C D Pauza; J L Markley; B F Volkman
Journal:  Biochemistry       Date:  2001-10-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.